Trial · NCT07884786
Effects of Myofascial Release on Postural Balance and Cervical Muscle Function in Benign Paroxysmal Positional Vertigo
NCT07884786, Not applicable, Completed, Karabuk University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Myofascial Release on Postural Balance and Cervical Muscle Function in Benign Paroxysmal Positional Vertigo. Trials, record NCT07884786. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07884786
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Myofascial Release on Postural Balance and Cervical Muscle Function in Benign Paroxysmal Positional Vertigo
- NCT number
- NCT07884786
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 40 participants, actual
- Lead sponsor
- Karabuk University
- Conditions
- Benign Paroxysmal Positional Vertigo
- Interventions
- Home-Based Balance Exercise Program, Myofascial Release Therapy
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Postural Sway | Baseline and Week 6 | Changes in anteroposterior and mediolateral postural sway measured using the Bertec Balance Legacy System under eyes-open and eyes-closed conditions on firm and foam surfaces. |
| Secondary | Change in Limits of Stability | Baseline and Week 6 | Anterior, posterior, right, left, and total limits of stability obtained from the Bertec Balance Legacy System. |
| Secondary | Change in Postural Alignment | Baseline and Week 6 | PostureScreenMobile-derived anterior cervical tilt, shoulder alignment, and other posture measures; displacements reported in centimeters. |
| Secondary | Change in Cervical Range of Motion | Baseline and Week 6 | Active and passive cervical flexion/extension, lateral flexion and rotation assessed with a universal goniometer in degrees. |
| Secondary | Change in Cervical and Scapular Muscle Strength | Baseline and Week 6 | Cervical flexor/extensor and upper/middle/lower trapezius isometric force measured by dynamometry in newtons. |
| Secondary | Change in Cervical Muscle Activation by sEMG | Baseline and Week 6 | Right and left sternocleidomastoid and upper trapezius surface electromyography; root mean square activity in microvolts, analyzed during a 5-second maximum voluntary contraction. |
| Secondary | Change in Dynamic Gait Index Score | Baseline and Week 6 | Eight walking and functional gait activities, total score 0-24; higher scores indicate better performance. |
| Secondary | Change in Vertigo Symptom Scale-Short Form Score | Baseline and Week 6 | 15-item symptom questionnaire with item responses from 0 to 4, including vestibular and anxiety-related symptom dimensions. |
| Secondary | Change in Dizziness Handicap Inventory Score | Baseline and Week 6 | 25-item questionnaire with a total score of 0-100; higher scores indicate greater dizziness-related handicap. |
| Secondary | Change in Dizziness Severity | Baseline and Week 6 | Participant-reported dizziness intensity measured using a 0-10 visual analogue scale. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07884786
GET https://conductscience.org/api/trials/v1/NCT07884786/registered